All ipos in reality are available at heavy discount to issue price. There will be heavy sellers on listing day.This company is not even up to standard of HDIL.
FAIR VALUE FOR THIS STOCK IS BETWEEN 150-180 RS. ABOVE THAT IT IS VERY EXPENSIVE. REMEMEBR I PRDICTED EXCELLENT LISTING OF COX AND KINGS WHICH WAS THE ONLY IPO PRICED WELL. OTHER THAN THAT DB CORP MIGHT GIVE LISTING GAINS OF 20-30%.
Godrej Properties is a very good script with rating of 4 in 5 & certainly will start from 580-590 at listing as well as should included in the long term portfolio
godrej properties IPO is going you hansome profit once it is allotted @enjoy the benefit do not hurry to sell for small ga me .wait for few months @see good amount coming to you.Good Luck to allotees
HI, The issue has hardly found favour with retail and non instnl investors. Their under subscribed portion will be allotted to QIBs.
With less number of shares with small guys(retail) and no pressure from the NII's who would need to make a quick get away from all IPOs, there is a distinct possibility that the share will not fall drastically below offer price. In fact may see some gains.
Also factor in the Godrej name. Quality institutional applications have come in.
Dear Mr. Vijai, Please do not apply in either of these issues because they are not the worth the money paid for. One Cox & Kings was an exception and investment in either of these companies will result in evaporation of your Capital by at least 25%. Decision is yours because money is yours. Better to avoid a couple of good issues rather investing in 1 bad issue.
I FIND MANY PEOPLE EXHORTING OTHERS FOR NOT APPLYING. ACTUALY IT IS NOT REQUIRED,NOBODY WANTS TO LOSS MONEY ; SO IF THEY FIND THE ISSUE USELESS THEY DO NOT APPLY.IT IS CLEAR FROM HNI & RETAIL FIGURES.WHATEVER SUBSCRIPTION IS SHOWN UNDER THE LAST CATEGORY IS FOR KOSHTAK APPLNS SOLD OUT. OTHERS ARE LAMENTING THE SEBI/GOVT ROLE. THEY SHOULS KNOW THAT GOVT DOES NOT WANT THE RETAIL INVESTORS TO GO FOR THE IPOS AS IT WILL RESULT IN CRASHING OF THE SECONDRY MARKET.